Navigating Reproductive Care in Patients With Inflammatory Bowel Disease: A Comprehensive Review Crohns Colitis. 2024 Oct 30;18(Supplement_2):ii16-ii30.doi: 10.1093/ecco-jcc/jjae048. Paula Sousa 1, Javier P Gisbert 2, Mette Julsgaard 3 4, Christian Philipp Selinger 5 6, María Chaparro 2 |
Author information 1Department of Gastroenterology, Hospital São Teotónio - Unidade Local de Saúde Dão Lafões, Viseu, Portugal. 2Department of Gastroenterology, Inflammatory Bowel Disease Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa [IIS-Princesa], Universidad Autónoma de Madrid [UAM], Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas [CIBEREHD], Madrid, Spain. 3Department of Hepatology & Gastroenterology, Aarhus University Hospital, Aarhus, Denmark. 4Centre for Molecular Prediction of Inflammatory Bowel Disease [PREDICT], Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark. 5Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK. 6University of Leeds, Leeds, UK. Abstract Inflammatory bowel disease [IBD] is often diagnosed in patients during their reproductive years. It is crucial that both healthcare providers and patients are adequately informed to avoid misguided decisions regarding family planning. One of the most important aspects during conception and pregnancy is to maintain disease remission, as disease activity is associated with adverse pregnancy outcomes. Apart from methotrexate, most conventional drugs used in IBD are considered low risk during conception and pregnancy. For newer agents, evidence is still limited. If needed, surgery must not be postponed and should ideally be performed in specialized centres. In most patients, delivery should be vaginal except for patients with complex perianal disease, with an ileoanal pouch anastomosis, or if there is an obstetric contraindication. In children exposed to biological treatments during pregnancy, the risk of infections appears to be low, and psychomotor development is probably not affected. Regarding immunizations, the standard vaccination schedule for inactivated vaccines should be followed for children exposed to biologics in utero. In the case of live vaccines, such as rotavirus, decisions should be individualized and take into consideration the risk-benefit ratio, particularly in developing countries. In this review, we provide a comprehensive and updated overview of aspects related to fertility, pregnancy, breastfeeding, and the impact on the care of children born to mothers with IBD. Both the available evidence and areas of uncertainty are discussed, with the goal of assisting healthcare professionals caring for IBD patients during this important stage of their lives. Keywords: Crohn’s disease; Fertility; breastfeeding; gestation; inflammatory bowel disease; lactation; offspring; pregnancy; ulcerative colitis. |
© Copyright 2013-2024 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only.
Use of this website is governed by the GIHF terms of use and privacy statement.